空气污染和对心力衰竭的暴露性影响
Lavanya Bellumkonda1, Tasveer Khawaja2, Sadeer Al-Kindi3
1Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (L.B.).
Circulation. Heart failure
|December 5, 2025
概括
空气污染显著推动心力衰竭的发展和恶化. 本综述综合了有关空气污染的证据.
科学领域:
- 环境健康 环境健康
- 心血管医学 心血管医学
- 公共卫生 公共卫生
背景情况:
- 空气污染是导致心血管疾病的主要全球环境健康风险因素.
- 新出现的证据凸显了空气污染在心力衰竭发病,进展和预后方面的作用.
- 空气污染被认为是暴露组的一部分,包括终身环境,社会和行为暴露.
研究的目的:
- 综合机械,实验,临床和流行病学证据,将空气污染与心力衰竭联系起来.
- 检查空气污染和其他加剧心力衰竭风险的暴露因素之间的相互作用.
- 提出风险沟通,减轻和临床管理风险的策略,对心力衰竭患者的空气污染暴露.
主要方法:
- 对空气污染和心力衰竭之间的机械联系的实验数据的审查.
- 对空气污染暴露和心力衰竭进展的实验,临床和流行病学研究的综合.
- 分析空气污染与社会和环境暴露因素的相互作用.
主要成果:
- 实验数据显示了连接空气污染与心力衰竭的机制性途径.
- 短期和长期的空气污染暴露都与心力衰竭进展的增加有关.
- 空气污染加剧了脆弱性,特别是在边缘化人口中,通过与其他暴露性领域的相互作用.
结论:
- 空气污染是导致心力衰竭的关键,可修改的危险因素.
- 了解暴露性相互作用对于解决心力衰竭中的健康差异至关重要.
- 需要临床框架来评估和管理心力衰竭患者的空气污染暴露,以减轻心血管影响.
相关概念视频
Heart Failure I: Introduction
670
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
670
Heart Failure III: Clinical Manifestations
446
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
446
Heart Failure II: Pathophysiology
685
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
685
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K


